Brisbane researchers are taking a major step forward in the battle to cure an aggressive and generally fatal form of brain cancer.
Clinical trials are underway for the promising glioblastoma therapy, which could also be used to fight a range of other cancers.
@njkelly9#9News
BIO | Cyteph CEO, Dr @melijknight, is on the ground at #BIO2023 in #Boston to build connections with decision makers in the biotech and pharma industries. She’s joined by a strong contingent of Queenslanders too 👉 https://t.co/30vXJSx7jI @IAmBiotech#medicalresearch#biotech
PRESENTATION | Co-inventor of @cyteph's CYT-AT1, Dr Paulo Martins, will present an abstract entitled ‘Off-the-shelf CAR T cell immunotherapy for glioblastoma’ at the Elevator Pitch Presentation at the @ISCTglobal conference today 👉 https://t.co/X8EsVje1YH #ISCT2023#cellandgene
Cyteph secures vital funding for brain cancer immunotherapy clinical trial https://t.co/72JAyMLYfj
More details on technology and platform: https://t.co/skOWyOCBsp
https://t.co/q6slL4Jd4z
A potential cure for an aggressive brain cancer has been given a vital funding boost with a clinical trial set to get underway in October. The ground-breaking research could lead to next-generation immunotherapy delivered to patients faster | @QIMRBerghofer @PipSheehan
🔉 MEDIA | The @australian's @TimDoddEDU has has published an article summarising the #CUREator funding announcement. Cyteph received a $1.5m grant, a significant boost for our efforts to positively contribute to the cancer therapeutics space👉 https://t.co/Hshp3v9Chf
📺 VIDEO | Take a moment to watch @QIMRBerghofer's Professor Rajiv Khanna, as he shares detailed insight into the science backing
@Cyteph – and our vision to positively contribute to the #cancertherapeutics space 👉https://t.co/AorMjVvtTV #medicalresearch#biotechnology
�� MEDIA RELEASE | Welcome to @Cyteph. A Company born from more than 15 years of research by distinguished scientist, Professor Rajiv Khanna, and his team at @QIMRBerghofer – and this week, a recipient of a $1.5m #CUREator grant too 👉 https://t.co/OQmxhnDZvX